The estimated mortality is highest in Maine and West Virginia, lowest in Utah.
In patients with stable atherosclerotic vascular disease, treatment with low-dose rivaroxaban plus aspirin halved the incidence of ischemic...
In vitro studies show strong results for spray-dried plasma, which could have implications on the battlefield.
Dr. Cynthia Dunbar, of the NIH, talks about the “critical mass of successes” in hematology and what is coming in the future.
Early research sheds light on sex differences in thrombosis risk.
From the Journals
Diagnosis appears to be the time with greatest risk.
Eltrombopag, from Novartis, will get expedited review for first-line treatment of severe aplastic anemia. It is already approved as a second-line...
This is the first FDA approval for hydroxyurea in pediatric patients with sickle cell anemia.
Zika RNA can persist in blood components for about up to 3 months.
CONCORD, N.C. – Transitional programs could help teenage patients continue self-care and avoid risk behaviors.